Pazopanib (200 mg)

admin — Wed, 18 Feb 2026 10:55:09 +0000

Overview: Dasazest 70 Tablets contain Dasatinib (70 mg) and are prescribed as an oral targeted anticancer medicine used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) by inhibiting BCR-ABL tyrosine kinase. Key Benefits: – Targets BCR-ABL signaling to slow leukemia progression – Oral dosing for convenient administration – Used in CML and Ph+ ALL treatment protocols Composition: Dasatinib (70 mg) How It Works: Dasatinib is a tyrosine kinase inhibitor that blocks the BCR-ABL fusion protein and other kinases involved in malignant cell signaling, reducing cancer cell proliferation and disease progression. Usage Instructions: – Take exactly as directed by your healthcare provider – Swallow the tablet whole with water, with or without food – Do not crush or chew the tablet Side Effects: – Diarrhea, nausea, vomiting – Headache, fatigue, rash – Low blood counts increasing infection risk Precautions: – Monitor blood counts and liver function regularly during treatment – Not recommended during pregnancy or breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

CML targeted therapy – Globalstar International

Pazopanib (200 mg)